Page last updated: 2024-10-30

beta-lapachone and Acute Disease

beta-lapachone has been researched along with Acute Disease in 2 studies

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

Acute Disease: Disease having a short and relatively severe course.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cascabulho, CM1
Meuser-Batista, M1
Moura, KCG1
Pinto, MDC1
Duque, TLA1
Demarque, KC1
Guimarães, ACR1
Manso, PPA1
Pelajo-Machado, M1
Oliveira, GM1
Castro, SL1
Menna-Barreto, RF1
Li, CJ1
Zhang, LJ1
Dezube, BJ1
Crumpacker, CS1
Pardee, AB1

Other Studies

2 other studies available for beta-lapachone and Acute Disease

ArticleYear
Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection.
    Memorias do Instituto Oswaldo Cruz, 2020, Volume: 115

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Chagas Disease; Disease Models, Animal; Electrocar

2020
Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Mar-01, Volume: 90, Issue:5

    Topics: Acute Disease; Antiviral Agents; Camptothecin; Cells, Cultured; Chronic Disease; Curcumin; Gene Expr

1993